These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9838346)

  • 21. Long-term follow-up (5 and 10 years) in recipients of HLA identical living related donor kidney grafts receiving continuous cyclosporine compared with azathioprine.
    MacDonald AS; Belitsky P; Bitter-Suermann H; Lawen J; MacSween M; Kiberd B; West K; McAlister VC
    Transplant Proc; 1997; 29(1-2):190. PubMed ID: 9122958
    [No Abstract]   [Full Text] [Related]  

  • 22. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU; Rahman M; Wahab MA; Kibria G; Rahman S; Jinnat S
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract]   [Full Text] [Related]  

  • 23. Donor specific transfusion in kidney transplantation: effect of different immunosuppressive protocols on graft outcome.
    Barbari A; Stephan A; Masri MA; Joubran N; Dagher O; Kamel G
    Transplant Proc; 2001 Aug; 33(5):2787-8. PubMed ID: 11498161
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic rejection in cyclosporin A treated renal allograft recipients with allopeptide reactive T cells.
    Iniotaki-Theodoraki A; Boletis J; Stamatiadis D; Choremi H; Kostakis A
    Transplant Proc; 1999; 31(1-2):1168-70. PubMed ID: 10083522
    [No Abstract]   [Full Text] [Related]  

  • 25. Transplantation without maintenance corticosteroids in 1-haplotype and 2-haplotype HLA matched living-related renal transplant recipients treated with mycophenolate mofetil and cyclosporine.
    Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
    Transplant Proc; 1999; 31(1-2):744-5. PubMed ID: 10083317
    [No Abstract]   [Full Text] [Related]  

  • 26. Ten years after: long-term effects of cyclosporine-based immunosuppression on renal allograft recipients.
    Kondo T; Kinukawa T; Takeuchi N; Hattori R; Ono Y; Matsuura O; Fujita T; Ohshima S
    Transplant Proc; 1998 Nov; 30(7):3530-2. PubMed ID: 9838546
    [No Abstract]   [Full Text] [Related]  

  • 27. Does low-dose allopurinol, with azathioprine, cyclosporin and prednisolone, improve renal transplant immunosuppression?
    Chocair PR; Duley JA; Cameron JS; Arap S; Ianhez L; Sabbaga E; Simmonds HA
    Adv Exp Med Biol; 1994; 370():205-8. PubMed ID: 7660891
    [No Abstract]   [Full Text] [Related]  

  • 28. Results of renal transplantation over 20 years after surgery, using azathioprine and low-dose prednisolone as the sole immunosuppression.
    Yoshimura N; Okamoto M; Akioka K; Nakamura K; Ushigome H; Kadotani Y; Nobori S; Higuchi A; Ohmori Y
    Transplant Proc; 2003 Feb; 35(1):143-4. PubMed ID: 12591340
    [No Abstract]   [Full Text] [Related]  

  • 29. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 30. First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation.
    Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
    Transplant Proc; 1992 Oct; 24(5):2241-2. PubMed ID: 1413040
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized trial of cyclosporine and prednisolone versus cyclosporine, azathioprine, and prednisolone in primary cadaveric renal transplantation.
    Lindholm A; Albrechtsen D; Tufveson G; Karlberg I; Persson NH; Groth CG
    Transplantation; 1992 Oct; 54(4):624-31. PubMed ID: 1412754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
    Sakhuja V; Sharma UK; Jha V; Minz M; Chugh KS
    Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
    [No Abstract]   [Full Text] [Related]  

  • 33. Results of various immunosuppressive regimens at our transplantation center.
    Karakayali H; Moray G; Demirağ A; Akkoç H; Haberal M
    Transplant Proc; 1998 Nov; 30(7):3101-2. PubMed ID: 9838368
    [No Abstract]   [Full Text] [Related]  

  • 34. Single-center study utilizing C(2) level as monitoring tool in de novo renal transplant recipients treated with Neoral.
    Keshavamurthy M; Al Ahmadi I; Mohammed Raza S; Baynton R; Al Meshari K; Al Shaibani K
    Transplant Proc; 2001; 33(7-8):3112-4. PubMed ID: 11750338
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical assessment of trough levels for monitoring of rejection in cyclosporine-treated kidney transplant recipients.
    Takahara S; Namiki M; Kokado Y; Kameoka H; Okuyama A
    Int Urol Nephrol; 1996; 28(3):431-8. PubMed ID: 8899485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two cases of tacrolimus-induced alopecia following kidney transplantation.
    Ushigome H; Yoshimura N; Okamoto M; Najima H; Hamajima T; Nakai I; Oka T
    Transplant Proc; 1999 Nov; 31(7):2885-6. PubMed ID: 10578326
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment.
    Allegra A; Corica F; Ientile R; Corsonello A; Sparacino V; Accettola F; Caputo F; Macaione S; Buemi M
    Magnes Res; 1998 Mar; 11(1):11-8. PubMed ID: 9595545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.
    Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S; Chiewsilp P; Leenanupunth C; Kochakarn W
    Transplant Proc; 1998 Nov; 30(7):3576-7. PubMed ID: 9838566
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of various immunosuppressive regimes in second renal transplants.
    Toronyi E; Remport A; Járay J; Máthé Z; Borka P; Perner F
    Transplant Proc; 2001 May; 33(3):2315-6. PubMed ID: 11377543
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell-mediated immune responses in renal transplant recipients treated with cyclosporin and prednisolone with or without azathioprine.
    Wramner L; Mjörnstedt L; Rydberg L; Olausson M
    Scand J Immunol; 1993 Jun; 37(6):656-60. PubMed ID: 8316763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.